Skip to main content
. 2006 Jan 15;4(1):48–51. doi: 10.1186/1897-4287-4-1-48

Table 2.

Prevalence of NOD2 3020insC mutation in breast cancer patients, according to age at onset

Age groups Prevalence of NOD2 3020insC
<41 0% (0/10)

41-50 9.7% (3/31)

51-60 17% (8/46)*

61-70 7.3% (4/55)

>70 4.9% (2/41)

total 9.1% (17/185)

* - statistically significant difference as compared to population controls (7.7% (75/974); OR = 2.5, p < 0.05)